Duality Advisers, LP Axonics, Inc. Transaction History

Duality Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$47.99 - $60.21 $3,455 - $4,335	-72 Reduced 0.24%	29,367 $1.48 Million
Q1 2023 Jun 27, 2023	BUY	$52.6 - $67.34 $33,664 - $43,097	640 Added 2.22%	29,439 $1.61 Million
Q4 2022 Feb 07, 2023	BUY	$59.56 - $76.6 $150,329 - $193,338	2,524 Added 9.61%	28,799 $1.8 Million
Q3 2022 Nov 03, 2022	BUY	$57.96 - $78.12 $1.52 Million - $2.05 Million	26,275 New	26,275 $1.85 Million

201

41.6M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.